Chardan Capital Reaffirms Neutral Rating for Allurion Technologies (NYSE:ALUR)

Allurion Technologies (NYSE:ALUR)‘s stock had its “neutral” rating reiterated by Chardan Capital in a research note issued on Thursday,Benzinga reports.

A number of other equities analysts have also weighed in on the company. Zacks Research upgraded Allurion Technologies to a “hold” rating in a research note on Tuesday, August 12th. Wall Street Zen lowered Allurion Technologies from a “hold” rating to a “strong sell” rating in a report on Saturday, August 16th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Allurion Technologies in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $9.25.

Allurion Technologies Stock Performance

NYSE ALUR traded down $0.07 on Thursday, hitting $1.32. The stock had a trading volume of 60,341 shares, compared to its average volume of 938,147. The firm has a 50-day moving average of $1.91 and a 200-day moving average of $2.36. Allurion Technologies has a 52-week low of $1.29 and a 52-week high of $16.81. The company has a market capitalization of $10.24 million, a price-to-earnings ratio of -0.13 and a beta of -0.46.

Allurion Technologies (NYSE:ALUR) last released its quarterly earnings results on Wednesday, November 12th. The company reported ($1.18) earnings per share for the quarter, topping the consensus estimate of ($2.45) by $1.27. The firm had revenue of $2.66 million during the quarter, compared to the consensus estimate of $2.05 million. As a group, research analysts anticipate that Allurion Technologies will post -9.96 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Allurion Technologies

A hedge fund recently bought a new stake in Allurion Technologies stock. XTX Topco Ltd bought a new position in Allurion Technologies, Inc. (NYSE:ALUR) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 13,037 shares of the company’s stock, valued at approximately $42,000. XTX Topco Ltd owned about 0.27% of Allurion Technologies at the end of the most recent reporting period. Institutional investors own 21.39% of the company’s stock.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.